Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):23–27. doi: 10.1136/hrt.76.3_suppl_3.23

Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view

J D Swales 1
PMCID: PMC484484  PMID: 8977362

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASSCHER A. W., ANSON S. G. A vascular permeability factor of renal origin. Nature. 1963 Jun 15;198:1097–1098. doi: 10.1038/1981097a0. [DOI] [PubMed] [Google Scholar]
  2. Alderman M. H., Madhavan S., Cohen H., Sealey J. E., Laragh J. H. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995 Jun;25(6):1144–1152. doi: 10.1161/01.hyp.25.6.1144. [DOI] [PubMed] [Google Scholar]
  3. Alderman M. H., Madhavan S., Ooi W. L., Cohen H., Sealey J. E., Laragh J. H. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991 Apr 18;324(16):1098–1104. doi: 10.1056/NEJM199104183241605. [DOI] [PubMed] [Google Scholar]
  4. Brunner H. R., Laragh J. H., Baer L., Newton M. A., Goodwin F. T., Krakoff L. R., Bard R. H., Bühler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972 Mar 2;286(9):441–449. doi: 10.1056/NEJM197203022860901. [DOI] [PubMed] [Google Scholar]
  5. Cuthbert M. F., Peart W. S. Studies on the identity of a vascular permeability factor of renal origin. Clin Sci. 1970 Mar;38(3):309–325. doi: 10.1042/cs0380309. [DOI] [PubMed] [Google Scholar]
  6. Doyle A. E., Jerums G., Johnston C. I., Louis W. J. Plasma renin levels and vascular complications in hypertension. Br Med J. 1973 Apr 28;2(5860):206–207. doi: 10.1136/bmj.2.5860.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farhy R. D., Ho K. L., Carretero O. A., Scicli A. G. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun. 1992 Jan 15;182(1):283–288. doi: 10.1016/s0006-291x(05)80142-1. [DOI] [PubMed] [Google Scholar]
  8. Faxon D. P., Creager M. A., Halperin J. L., Sussman H. A., Gavras H., Ryan T. J. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. Int J Cardiol. 1982;2(2):251–262. doi: 10.1016/0167-5273(82)90040-7. [DOI] [PubMed] [Google Scholar]
  9. Goldby F. S., Beilin L. J. How an acute rise in arterial pressure damages arterioles. Electron microscopic changes during angiotensin infusion. Cardiovasc Res. 1972 Sep;6(5):569–584. doi: 10.1093/cvr/6.5.569. [DOI] [PubMed] [Google Scholar]
  10. Goldby F. S., Beilin L. J. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc Res. 1972 Jul;6(4):384–390. doi: 10.1093/cvr/6.4.384. [DOI] [PubMed] [Google Scholar]
  11. Griffin S. A., Brown W. C., MacPherson F., McGrath J. C., Wilson V. G., Korsgaard N., Mulvany M. J., Lever A. F. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991 May;17(5):626–635. doi: 10.1161/01.hyp.17.5.626. [DOI] [PubMed] [Google Scholar]
  12. Harrap S. B., Mitchell G. A., Casley D. J., Mirakian C., Doyle A. E. Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats. Hypertension. 1993 Jan;21(1):50–55. doi: 10.1161/01.hyp.21.1.50. [DOI] [PubMed] [Google Scholar]
  13. Kaplan N. M. The prognostic implications of plasma renin in essential hypertension. JAMA. 1975 Jan 13;231(2):167–170. [PubMed] [Google Scholar]
  14. Kremer D., Lindop G., Brown W. C., Morton J. J., Robertson J. I. Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure. Cardiovasc Res. 1981 Jan;15(1):43–46. doi: 10.1093/cvr/15.1.43. [DOI] [PubMed] [Google Scholar]
  15. Meade T. W., Cooper J. A., Peart W. S. Plasma renin activity and ischemic heart disease. N Engl J Med. 1993 Aug 26;329(9):616–619. doi: 10.1056/NEJM199308263290905. [DOI] [PubMed] [Google Scholar]
  16. Meade T. W., Imeson J. D., Gordon D., Peart W. S. The epidemiology of plasma renin. Clin Sci (Lond) 1983 Mar;64(3):273–280. doi: 10.1042/cs0640273. [DOI] [PubMed] [Google Scholar]
  17. Mroczek W. J., Finnerty F. A., Catt K. J. Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet. 1973 Sep 1;2(7827):464–468. doi: 10.1016/s0140-6736(73)92069-2. [DOI] [PubMed] [Google Scholar]
  18. Möhring J., Petri M., Szokol M., Haack D., Möhring B. Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol. 1976 Mar;230(3):849–857. doi: 10.1152/ajplegacy.1976.230.3.849. [DOI] [PubMed] [Google Scholar]
  19. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  20. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  21. Powell J. S., Clozel J. P., Müller R. K., Kuhn H., Hefti F., Hosang M., Baumgartner H. R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 Jul 14;245(4914):186–188. doi: 10.1126/science.2526370. [DOI] [PubMed] [Google Scholar]
  22. Rosenqvist M. Atrial pacing for sick sinus syndrome. Clin Cardiol. 1990 Jan;13(1):43–47. doi: 10.1002/clc.4960130108. [DOI] [PubMed] [Google Scholar]
  23. Russell G. I., Bing R. F., Thurston H., Swales J. D. Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features. Q J Med. 1980;49(195):385–394. [PubMed] [Google Scholar]
  24. Schiffrin E. L., Deng L. Y., Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994 Jan;23(1):83–91. doi: 10.1161/01.hyp.23.1.83. [DOI] [PubMed] [Google Scholar]
  25. Stroobandt R., Fagard R., Amery A. K. Are patients with essential hypertension and low renin protected against stroke and heart attack? Am Heart J. 1973 Dec;86(6):781–787. doi: 10.1016/0002-8703(73)90281-0. [DOI] [PubMed] [Google Scholar]
  26. Thybo N. K., Stephens N., Cooper A., Aalkjaer C., Heagerty A. M., Mulvany M. J. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995 Apr;25(4 Pt 1):474–481. doi: 10.1161/01.hyp.25.4.474. [DOI] [PubMed] [Google Scholar]
  27. Wikstrand J., Warnold I., Olsson G., Tuomilehto J., Elmfeldt D., Berglund G. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA. 1988 Apr 1;259(13):1976–1982. [PubMed] [Google Scholar]
  28. Wilhelmsen L., Berglund G., Elmfeldt D., Fitzsimons T., Holzgreve H., Hosie J., Hörnkvist P. E., Pennert K., Tuomilehto J., Wedel H. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987 Oct;5(5):561–572. doi: 10.1097/00004872-198710000-00009. [DOI] [PubMed] [Google Scholar]
  29. Williams B., Baker A. Q., Gallacher B., Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension. 1995 May;25(5):913–917. doi: 10.1161/01.hyp.25.5.913. [DOI] [PubMed] [Google Scholar]
  30. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES